Changes of Heart Rate Variability during Methylphenidate Treatment in Attention-Deficit Hyperactivity Disorder Children: A 12-Week Prospective Study.
10.3349/ymj.2015.56.5.1365
- Author:
Hayeon Jennifer KIM
1
;
Jaewon YANG
;
Moon Soo LEE
Author Information
1. Department of Psychiatry, Korea University, College of Medicine, Seoul, Korea. npboard@korea.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Attention deficit hyperactivity disorder;
heart rate variability;
methylphenidate;
autonomic nervous system
- MeSH:
Adolescent;
Attention/drug effects/*physiology;
Attention Deficit Disorder with Hyperactivity/diagnosis/*drug therapy;
Autonomic Nervous System/physiopathology;
Biomarkers;
Central Nervous System Stimulants/pharmacology/*therapeutic use;
Child;
Female;
Heart Rate/*drug effects/physiology;
Humans;
Male;
Methylphenidate/pharmacology/*therapeutic use;
Prospective Studies;
Republic of Korea;
Treatment Outcome
- From:Yonsei Medical Journal
2015;56(5):1365-1371
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The aim of this study was to clarify the relationship between the autonomic nervous system and attention deficit hyperactivity disorder (ADHD) rating scales and to evaluate the usefulness of heart rate variability (HRV) as a psychophysiological biomarker for ADHD. MATERIALS AND METHODS: Subjects were recruited from outpatients in the Department of Child and Adolescent Psychiatry at the Korea University Medical Center from August 2007 to December 2010. Subjects received methylphenidate. Time- and frequency-domain analyses of HRV, the Korean ADHD rating scale (K-ARS), and computerized ADHD diagnostic system were evaluated before treatment. After a 12-week period of medication administration, we repeated the HRV measurements and K-ARS rating. RESULTS: Eighty-six subjects were initially enrolled and 37 participants completed the 12-week treatment and HRV measurements subsequent to the treatment. Significant correlations were found between the K-ARS inattention score and some HRV parameters. All of the HRV parameters, except the standard deviations of the normal-to-normal interval, very low frequency, and low frequency to high frequency, showed a significant positive correlation between baseline and endpoint measures in completers. High frequency (HF) and the square root of the mean squared differences of successive normal-to-normal intervals (RMSSD), which are related to parasympathetic vagal tone, showed significant decreases from baseline to endpoint. CONCLUSION: The HRV test was shown to be reproducible. The decrease in HF and RMSSD suggests that parasympathetic dominance in ADHD can be altered by methylphenidate treatment. It also shows the possibility that HRV parameters can be used as psychophysiological markers in the treatment of ADHD.
